Visualizing production of beta interferon by astrocytes and microglia in brain of la crosse virus-infected mice

Journal of Virology

Volumn 86, Issue 20, 2012, Pages 11223-11230

  Kallfass, Carsten ^a   Ackerman, Andreas ^a   Lienenklaus, Stefan ^b   Weiss, Siegfried ^b   Heimrich, Bernd ^a   Staeheli, Peter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; FIREFLY LUCIFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CALIFORNIA ENCEPHALITIS; CELL COUNT; CELL TYPE; CYTOCHEMISTRY; CYTOKINE PRODUCTION; GENE EXPRESSION; GLIA CELL; INFECTION SENSITIVITY; LA CROSSE VIRUS; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; VIRUS MUTANT; WILD TYPE;

ANIMALS; ASTROCYTES; BRAIN; ENCEPHALITIS, CALIFORNIA; INTERFERON-BETA; LA CROSSE VIRUS; LUCIFERASES, FIREFLY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; NEURONS; PROMOTER REGIONS, GENETIC;

LA CROSSE VIRUS; MAMMALIA; MUS;

EID: 84869036198     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01093-12     Document Type: Article

References (29)

1. Asselin-Paturel C, et al. 2001. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2:1144-1150.
2. Asselin-Paturel C, Trinchieri G. 2005. Production of type I interferons: plasmacytoid dendritic cells and beyond. J. Exp. Med. 202:461-465.
3. Bennett RS, et al. 2008. La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys. Virol. J. 5:25. doi:10.1186/1743-422X-5-25.
4. Blakqori G, et al. 2007. La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J. Virol. 81:4991-4999.
5. Blakqori G, Weber F. 2005. Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. J. Virol. 79:10420-10428.
6. Brennan K, Bowie AG. 2010. Activation of host pattern recognition receptors by viruses. Curr. Opin. Microbiol. 13:503-507.
7. Cervantes-Barragan L, et al. 2007. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109: 1131-1137.
8. Chen J, Baig E, Fish EN. 2004. Diversity and relatedness among the type I interferons. J. Interferon Cytokine Res. 24:687-698.
9. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8:265-277.
10. Delhaye S, et al. 2006. Neurons produce type I interferon during viral encephalitis. Proc. Natl. Acad. Sci. U. S. A. 103:7835-7840.
11. Dewachter I, et al. 2002. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J. Neurosci. 22:3445-3453.
12. - but not plasmacytoid dendritic cells. J. Exp. Med. 205:1621-1634.
13. Hart DN, Fabre JW. 1981. Demonstration and characterization of Iapositive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain. J. Exp. Med. 154:347-361.
14. Hemmi H, Akira S. 2005. TLR signalling and the function of dendritic cells. Chem. Immunol. Allergy 86:120-135.
15. Hillyer P, et al.17 January 2012, posting date. Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent. Immunol. Cell Biol. doi:10.1038/icb.2011.109.
16. Janssen R, Gonzalez-Scarano F, Nathanson N. 1984. Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus. Lab. Invest. 50:447-455.
17. Kumagai Y, et al. 2007. Alveolar macrophages are the primary interferonalpha producer in pulmonary infection with RNA viruses. Immunity 27: 240-252.
18. Lienenklaus S, et al. 2009. Novel reporter mouse reveals constitutive and inflammatory expression of IFN-beta in vivo. J. Immunol. 183:3229-3236.
19. Pestka S, Krause CD, Walter MR. 2004. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202:8-32.
20. Prinz M, et al. 2008. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28:675-686.
21. Rehwinkel J, et al. 2010. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140:397-408.
22. Roth-Cross JK, Bender SJ, Weiss SR. 2008. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J. Virol. 82:9829-9838.
23. Rubio N, Palomo M, Alcami A. 2010. Interferon-alpha/beta genes are up-regulated in murine brain astrocytes after infection with Theiler's murine encephalomyelitis virus. J. Interferon Cytokine Res. 30:253-262.
24. Smit JJ, Rudd BD, Lukacs NW. 2006. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J. Exp. Med. 203:1153-1159.
25. Solodova E, Jablonska J, Weiss S, Lienenklaus S. 2011. Production of IFN-beta during Listeria monocytogenes infection is restricted to monocyte/macrophage lineage. PLoS One 6:e18543. doi:10.1371/ journal.pone.0018543.
26. Tedeschi B, Barrett JN, Keane RW. 1986. Astrocytes produce interferon that enhances the expression of H-2 antigens on a subpopulation of brain cells. J. Cell Biol. 102:2244-2253.
27. Verbruggen P, et al. 2011. Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II. J. Biol. Chem. 286:3681-3692.
28. Zhao M, Zhang J, Phatnani H, Scheu S, Maniatis T. 2012. Stochastic expression of the interferon-beta gene. PLoS Biol. 10:e1001249. doi: 10.1371/journal.pbio.1001249.
29. Zhu Y, et al. 2001. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev. 15:859-876.